Evaluation of the Clinical Efficacy and Safety of Gongyanping Capsule Combined with Tinidazole Tablets in the Treatment of Patients with Acute Cervicitis

Abstract

Objective: To study the therapeutic effect of Gongyanping capsule+tinidazole tablets in patients with acute cervicitis. Methods: Data were collected from 84 patients with acute cervicitis admitted to our hospital from January 2020 to October 2020. The “double-blind method” was divided into reference group (tinidazole tablets, n=42) and combination group (tinidazole). Azole tablets + Gongyanping capsule, n=42), compare the effectiveness of the two groups. Results: There was no difference in immune function before medication, and there was no difference in adverse reactions between the two groups after medication, P>0.05; after medication, compared with the reference group, the combination group had higher IgA, IgG, IgM indicators; the combination group had higher effective rates (95.24%) was higher than the reference group (76.19%), x2=4.7639, p=0.0290, P<0.05. Conclusions: Combination therapy for acute cervicitis can improve the efficacy, is safe and reliable, and is worthy of praise.